In 2018, it was revealed that up to 4 million bottles of Valsartan, a popular heart medication, were tainted with dangerous levels of NDMA, a substance linked to cancer.
If you’re taking Valsartan or have taken it in the past, you might be wondering if you’re eligible to join the lawsuit. Or maybe you’re just curious about what’s going on. Either way, you’re in the right place.
The objective of this article is to help the common man learn more about the Valsartan cancer lawsuit. This helps them understand their current situation and check whether they are eligible.
Websites like Lawsuit Legal News also help with this. The site contains plenty of information about all the current lawsuits in the US. Lawsuit Legal News also updates lawsuit-related information on a regular basis, making it easy for individuals to learn more about them.
1. What are the current legal proceedings related to the Valsartan Lawsuits
The Valsartan recall is currently being handled through a legal process called Multi-District Litigation (MDL), which is taking place in the United States District Court for the District of New Jersey.
This case is known as In re: Valsartan, Losartan, and Irbesartan Products Liability Litigation, and it’s overseen by Judge Robert B. Kugler.
In this lawsuit, there are many different parties involved. The key defendants include major drug manufacturers like Zhejiang Huahai Pharmaceutical Co., Teva Pharmaceuticals, and Aurobindo Pharma.
On the retail side, CVS, Walgreens, and Walmart are named as defendants, along with wholesalers such as McKesson Corporation and Cardinal Health.
2. What led to the Valsartan recall?
The Valsartan recall was initiated due to the discovery of N-nitrosodimethylamine (NDMA) and later N-Nitrosodiethylamine (NDEA), both of which are classified as probable human carcinogens.
These impurities were found in some Valsartan products, which were manufactured by Zhejiang Huahai Pharmaceuticals and other companies.
The contamination probably happened because of changes in the manufacturing process of the active ingredient.
The plaintiffs, who are the people bringing the lawsuit, claim that these defendants were responsible for making and selling Valsartan that was contaminated.
The defendants, on the other hand, deny these claims. They argue about the levels of contaminants in the drugs and whether they are harmful enough to be considered cancer-causing.
3. What specific types of cancers are linked to the contaminated Valsartan?
The cancers most commonly linked to NDMA exposure include
- Liver cancer
- Kidney cancer
- Stomach cancer
4. How can I determine if I am eligible to join the Valsartan lawsuit?
To find out if you can join the Valsartan lawsuit, you need to consider a few things. First, there are different groups or “classes” you might be part of, depending on your situation.
The Consumer Economic Loss Class is for people who have lost money because they bought Valsartan that was contaminated. If you paid for and used the affected medication, you might be part of this group.
The Medical Monitoring Class is for those who, due to their exposure to the tainted Valsartan, need regular medical check-ups to watch for any potential health issues. This is important if you were exposed to NDMA and NDEA, the harmful substances found in the drugs.
The Personal Injury Class is for individuals who have been diagnosed with cancer or other serious health problems related to their use of Valsartan. If you have been diagnosed with such conditions, you could be eligible for this class.
Since each class has its own set of criteria based on how Valsartan contamination has affected people, you might fit into more than one class depending on your situation.
To figure out if you qualify, it’s best to talk to a Valsartan lawsuit attorney. They can help you go through your medical and purchase records to see where you stand and what benefits you might be entitled to.
5. What are the current settlement options and deadlines for those involved in the Valsartan recall lawsuit?
As of now, there are ongoing settlement negotiations in the Valsartan recall lawsuit. The plaintiffs have requested extensions for finalizing settlement agreements, which are key to resolving the claims. The deadlines for these settlements are:
- July 15, 2024: Deadline to finalize documents related to economic loss settlements.
- July 22, 2024: Deadline to finalize documents for personal injury settlements.
- September 30, 2024: Deadline for finalizing medical monitoring settlement documents.
